| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |